Navigation Links
Stemedica Announces the Appointment of Riccardo Nisato, MBA, PhD as Director of Manufacturing and Clinical Business Development for Stemedica International
Date:2/13/2009

uding his intimate interaction with researchers and clinicians involved in Phase I, Phase II studies and approved treatments derived from fetal and adult cells, combined with his years of consulting for medical technology companies will provide invaluable direction for our international development strategy," said Roger Howe, Chairman and CFO at Stemedica.

"The prospect that Stemedica International represents for establishing regulatory-approved clinical trials at high-accredited treatment facilities around the world, leading to successful treatment for patients with debilitating conditions, is an invigorating opportunity for me at this point in my career. I have been fortunate to extensively collaborate with researchers and surgeons involved in cell-based clinical trials and approved therapies for skin burn treatments for children and adults, so I am intimately aware of the difference that Stemedica International will make in the future. It's an honor to be in at ground level, working to build Stemedica into a worldwide leader in the adult stem cell industry," said Dr. Nisato.

Dr. Nisato will report to Dr. Alex Kharazi, Vice President, Research & Manufacturing for Stemedica International's partner organization, Stemedica Cell Technologies and to Dr. Nikolai Tankovich, Chairman of Stemedica International and President and Medical Officer of Stemedica Cell Technologies.

"Dr. Nisato has the perfect combination of medical knowledge in pharmacology and cell biology as well as with medically-oriented business development that makes him the perfect choice for this significant new role. We are very fortunate to have attracted his interest and to have brought about this significant appointment. I am excited about extending our solid U.S. work to Europe under Dr. Nisato's strategic oversight," said Dr. Tankovich.

About Stemedica Cell Technologies, Inc.

Stemedica Cell Technologies Inc. (

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Dr Nabil Dib Takes on Special Advisor Role to the Stemedica Board of Directors
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stemedica Announces the Appointment of Riccardo Nisato, MBA, PhD as Director of Manufacturing and Clinical Business Development for Stemedica International
(Date:7/24/2014)... Pools and beaches are the place to be on hot ... small children, so Amica Insurance is sharing five ... for Disease Control and Prevention, children between the ages of ... and deaths. It’s important to know the best practices for ... the following tips from the American Red Cross:, ...
(Date:7/24/2014)... caffeine may worsen the hot flashes and night sweats ... through menopause, new survey data suggests. "While these ... intake may be useful for those postmenopausal women who ... Dr. Stephanie Faubion, director of the Women,s Health Clinic ... caffeine -- a stimulant found in coffee and colas ...
(Date:7/24/2014)... 2014 Horizon BCBSNJ’s second annual “Back ... family a rent-free week in a beautiful Lavallette shore ... Don’t miss your chance to win a week’s vacation ... all New Jersey residents, 25 or older.* Residents can ... http://www.facebook.com/HorizonBCBSNJ . , “A family vacation at the ...
(Date:7/24/2014)... PITTSBURGHComputer scientists at Carnegie Mellon University, working with ... Lawrence Berkeley National Laboratory, have devised a computational ... as normal breast cells turn malignant and as ... method for analyzing how genes interact with each ... report published today by the online journal ...
(Date:7/24/2014)... (Boston)--Minority women who received the Human Papillomavirus Vaccination ... rates of abnormal Pap test results than those ... the journal Sexually Transmitted Diseases . ... Health and School of Medicine conducted a cross-sectional ... undergoing routine cervical cytology testing. HPV status and ...
Breaking Medicine News(10 mins):Health News:Keep Kids Safe in the Water with 5 Tips from Amica 2Health News:Is Coffee Aggravating Your Hot Flashes? 2Health News:(Beach) Sands of Time Running out to Enter Horizon Blue Cross Blue Shield of New Jersey’s 2014 “Back to the Boardwalk” Sweepstakes 2Health News:Gene changes in breast cancer cells pinpointed with new computational method 2Health News:Gene changes in breast cancer cells pinpointed with new computational method 3
... say , THURSDAY, Feb. 11 (HealthDay News) -- Just ... chocolate appears to lower your risk of stroke or lessen ... the findings, based on a review of existing research, aren,t ... your heart. And dietitians say too much chocolate can be ...
... ... 11 getSTDtested.com, a physician driven, STD ... Goodbye" to encourage young women to take action to prevent chlamydia. ... cured with antibiotic treatment.  The campaign to " Kiss Chlamydia Goodbye " ...
... , MARINA DEL REY, Calif. , Feb. 11 ... Network Family, and CEO Dr. Richard Merkin have ... community service and dedication as a leading health care provider. ... of Commerce of the San Fernando Valley and Region, honored ...
... , , BRENTWOOD, Tenn. , Feb. ... present a free seminar, ADHD Kids: Getting Along Socially , ... at the Maryland Farms YMCA in Brentwood . It is ... Farms YMCA, to help support parents, school teachers, administrators and counselors, ...
... College of Georgia researchers are conducting the first FDA-approved clinical ... umbilical cord blood can improve the quality of life for ... 40 children age 2-12 whose parents have stored cord blood ... Umbilical cord blood is rich in stem cells, which can ...
... says more than 1,500 cases have been reported in New ... In a recent mumps outbreak occurring in the eastern United ... infectious illness got sick, health officials report. , A study ... Prevention tracked an ongoing outbreak of mumps, largely confined to ...
Cached Medicine News:Health News:Dark Chocolate May Lower Stroke Risk 2Health News:College Age Females Can 'Kiss Chlamydia Goodbye' for Valentine's Day 2Health News:College Age Females Can 'Kiss Chlamydia Goodbye' for Valentine's Day 3Health News:College Age Females Can 'Kiss Chlamydia Goodbye' for Valentine's Day 4Health News:College Age Females Can 'Kiss Chlamydia Goodbye' for Valentine's Day 5Health News:Lakeside Medical Organization, Dr. Richard Merkin, CEO, Honored by United Chambers of Commerce 2Health News:Learning Lab of Brentwood Leads Free ADHD Seminar 2Health News:Learning Lab of Brentwood Leads Free ADHD Seminar 3Health News:MCG to conduct first FDA-approved stem cell trial in pediatric cerebral palsy 2Health News:Vaccine Not Fail-Safe in Ongoing Mumps Outbreak 2Health News:Vaccine Not Fail-Safe in Ongoing Mumps Outbreak 3
(Date:7/24/2014)... , July 24, 2014 Consolidated Net ... Business Highlights   , India Business grew ... by 9.33% to Rs. 4,886.70 Mn Rest of World ... Europe Formulations Business grew by 34.53% to Rs. 977.26 Mn ... , Glenmark Pharmaceuticals Limited, the research-led global ...
(Date:7/24/2014)... -- Delivery of the Report will take 2-3 ... Photo - http://photos.prnewswire.com/prnh/20140723/129707 ... on Global and Chinese Hemodialysis Machine industry. The ... Machine including its classification, application and manufacturing technology. ... manufacturers of Hemodialysis Machine listing their product specification, ...
(Date:7/24/2014)... Cancer patients in the west of Scotland ... home when a new radiotherapy center opens near ... VAR ) has been selected to equip the new ... TrueBeam™ medical linear accelerators. Two of the ... radiosurgery treatments, will replace older treatment machines at the Beatson ...
Breaking Medicine Technology:Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 3Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 4Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 2Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 3Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 4Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 5Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland 2Varian Medical Systems Selected to Equip First Satellite Radiotherapy Center in Scotland 3
... N.J., Feb. 19, UCB (Euronext: UCB) and sanofi-aventis ... (FDA) approved a New Drug,Application (NDA) for XYZAL(R) ... indicated for the relief of,symptoms associated with indoor ... chronic idiopathic urticaria. XYZAL(R) tablets received FDA,approval on ...
... -Study Results Show Cethromycin Not Associated with QT Prolongation- ... -Favorable Cardiac Safety Profile Strengthens NDA-, CHICAGO, ... ADLS ), today announced positive results from Trial,CL07-001, a ... cethromycin. This study was conducted to evaluate the cardiac,safety ...
Cached Medicine Technology:FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria 2FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria 3FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria 4FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria 5Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin 2Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin 3Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin 4Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin 5Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin 6
The Accuref 8001 allows you to measure much smaller pupils than conventional units and 3 step Target light adjuster ensures accurate results....
... is an Auto Refractor/Keratometer with ... refinement. Electronic elevation, automatic alignment, ... accuracy and all the other ... Marco Automatic Refractors/Keratometer famous, make ...
Sterile perfluorocarbon for intraocular Application....
Sterile Silicone Oil for Intraocular Application....
Medicine Products: